Web Exclusive: Clinical Trials for CUP

Clinical trials for cancers of unknown primary patients. 

A listing of clinical trials for patients with cancers of unknown primary are listed below.  

Therapy: Treatment based on molecular profiling assay – paclitaxel, carboplatin, bevacizumab, erlotinib

Cancer: Carcinoma of Unknown Primary

Phase: II

Sponsor/Manufacturer: Sarah Cannon Research Institute/Genentech

Contact information: John D. Hainsworth, MD, 615-329-7274; jhainsworth@tnonc.com

Therapy: Avastin (bevacizumab)

Cancer: Neuroendocrine Carcinoma

Phase: III

Sponsor/Manufacturer: Southwest Oncology Group, National Cancer Institute

Contact information: James Yao, MD, 713-792-2828; jyao@mdanderson.org or 800-392-1611

Therapy: Taxotere (docetaxel), 5-FU (5-fluorouracil), Platinol (cisplatin)

Cancer: Squamous Cell or Undifferentiated Carcinoma

Phase: II

Sponsor/Manufacturer: M.D. Anderson Cancer Center/Sanofi-Aventis

Contact information: Ehab Y. Hanna, MD, 713-745-2672; eyhanna@mdanderson.org

Therapy: Xeloda (capecitabine)

Cancer: Solid Tumors and Adenocarcinoma of Unknown Primary

Phase: I/II

Sponsor/Manufacturer: Ohio State University Comprehensive Cancer Center

Contact information: OSU Cancer Clinical Trial Matching Service – 866-627-7616; osu@emergingmed.com

Therapy: Vectibix (panitumumab)

Cancer: Squamous Cell Carcinoma of the Head and Neck; Undifferentiated Carcinoma; Adenosquamous Cell Carcinoma

Phase: I

Sponsor/Manufacturer: Dana-Farber Cancer Institute; Brigham and Women’s Hospital; Massachusetts General Hospital/Amgen

Contact information: Lori J. Wirth, MD, 617-632-3090; lwirth@partners.org

Therapy: Nexavar (sorafenib)

Cancer: Advanced Solid Tumors

Phase: II

Sponsor/Manufacturer: University of California Davis

Contact information: UC Davis Clinical Trials Office – 916-734-3089 or Primo N. Lara, MD, 916-734-3772; primo.lara@ucdmc.ucdavis.edu

Therapy: Stereotactic Body Radiotherapy

Cancer: Spinal Neoplasms

Phase: I/II

Sponsor/Manufacturer: M.D. Anderson Cancer Center

Contact information: Eric L. Chang, MD, 713-563-2300; echang@mdanderson.org 

Investigators in clinical trials may be individual physicians, researchers at institutions, or pharmaceutical company representatives. The contact information given here was provided by those running these trials and was accurate at the time of publication. If you get a voice mail, leave the pertinent information. For additional trials, go to www.curetoday.com/trialcheck.

Talk about this article with other patients, caregivers, and advocates in the CURE discussion group.
CURE wants to hear from you! We are inviting you to Share Your Story with the readers of CURE. Submit your personal experience with cancer by visiting Share Your Story
Not yet receiving CURE in your mailbox? Sign up to receive CURE Magazine by visiting GetCureNow.com